Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-19

Clinical Trial Update: Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates a threshold nomogram-guided gonadotropin dosing strategy for ovulation induction in women with WHO Group II anovulatory in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonadotropin (gonadotropin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Anovulation, Infertility | Phase 4 | Status: COMPLETED